Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: A pilot study

Rhonda Robert, Patricia E. Blakeney, Cynthia Villarreal, Laura Rosenberg, Walter Meyer

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Objective: Pediatric burn patients often exhibit acute stress disorder (ASD) symptoms. Information on psychopharmacological treatment of ASD symptoms in children is scarce. This pilot study used a prospective, randomized, double-blind design to test whether thermally injured children suffering ASD symptoms benefit from imipramine. Method: Twenty-five children, aged 2 to 19 years, received either imipramine or chloral hydrate for 7 days. A structured interview (clinically useful, but validity and reliability not yet established) was used to assess the presence and frequency of ASD symptoms both before treatment and 3 times during the treatment period. Results: Eleven females and 14 males participated, with a mean total burn surface area of 45% (SD = 23%) and mean age of 8 years (SD = 6). Imipramine was more effective than chloral hydrate in treating ASD symptoms (χ 2 [1, N = 25] = 5.24, p < .02). Five of 13 were positive responders to chloral hydrate (38%). Ten of 12 were positive responders to low-dose imipramine (83%). Conclusions: This pilot study suggests a place for cautious initial use of imipramine to reduce ASD symptoms in burned children. Care must be taken to minimize cardiovascular risks in an off-label application of imipramine in children, especially those receiving additional medications.

Original languageEnglish (US)
Pages (from-to)873-882
Number of pages10
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume38
Issue number7
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Stress Disorders, Traumatic, Acute
Imipramine
Pediatrics
Chloral Hydrate
Therapeutics
Reproducibility of Results
Interviews

Keywords

  • Acute stress disorder
  • Imipramine
  • Medication therapy
  • Pharmacotherapy
  • Posttraumatic stress disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder : A pilot study. / Robert, Rhonda; Blakeney, Patricia E.; Villarreal, Cynthia; Rosenberg, Laura; Meyer, Walter.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 38, No. 7, 1999, p. 873-882.

Research output: Contribution to journalArticle

Robert, Rhonda ; Blakeney, Patricia E. ; Villarreal, Cynthia ; Rosenberg, Laura ; Meyer, Walter. / Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder : A pilot study. In: Journal of the American Academy of Child and Adolescent Psychiatry. 1999 ; Vol. 38, No. 7. pp. 873-882.
@article{f76c58f74f8046378479b0f732ad0690,
title = "Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: A pilot study",
abstract = "Objective: Pediatric burn patients often exhibit acute stress disorder (ASD) symptoms. Information on psychopharmacological treatment of ASD symptoms in children is scarce. This pilot study used a prospective, randomized, double-blind design to test whether thermally injured children suffering ASD symptoms benefit from imipramine. Method: Twenty-five children, aged 2 to 19 years, received either imipramine or chloral hydrate for 7 days. A structured interview (clinically useful, but validity and reliability not yet established) was used to assess the presence and frequency of ASD symptoms both before treatment and 3 times during the treatment period. Results: Eleven females and 14 males participated, with a mean total burn surface area of 45{\%} (SD = 23{\%}) and mean age of 8 years (SD = 6). Imipramine was more effective than chloral hydrate in treating ASD symptoms (χ 2 [1, N = 25] = 5.24, p < .02). Five of 13 were positive responders to chloral hydrate (38{\%}). Ten of 12 were positive responders to low-dose imipramine (83{\%}). Conclusions: This pilot study suggests a place for cautious initial use of imipramine to reduce ASD symptoms in burned children. Care must be taken to minimize cardiovascular risks in an off-label application of imipramine in children, especially those receiving additional medications.",
keywords = "Acute stress disorder, Imipramine, Medication therapy, Pharmacotherapy, Posttraumatic stress disorder",
author = "Rhonda Robert and Blakeney, {Patricia E.} and Cynthia Villarreal and Laura Rosenberg and Walter Meyer",
year = "1999",
doi = "10.1097/00004583-199907000-00018",
language = "English (US)",
volume = "38",
pages = "873--882",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder

T2 - A pilot study

AU - Robert, Rhonda

AU - Blakeney, Patricia E.

AU - Villarreal, Cynthia

AU - Rosenberg, Laura

AU - Meyer, Walter

PY - 1999

Y1 - 1999

N2 - Objective: Pediatric burn patients often exhibit acute stress disorder (ASD) symptoms. Information on psychopharmacological treatment of ASD symptoms in children is scarce. This pilot study used a prospective, randomized, double-blind design to test whether thermally injured children suffering ASD symptoms benefit from imipramine. Method: Twenty-five children, aged 2 to 19 years, received either imipramine or chloral hydrate for 7 days. A structured interview (clinically useful, but validity and reliability not yet established) was used to assess the presence and frequency of ASD symptoms both before treatment and 3 times during the treatment period. Results: Eleven females and 14 males participated, with a mean total burn surface area of 45% (SD = 23%) and mean age of 8 years (SD = 6). Imipramine was more effective than chloral hydrate in treating ASD symptoms (χ 2 [1, N = 25] = 5.24, p < .02). Five of 13 were positive responders to chloral hydrate (38%). Ten of 12 were positive responders to low-dose imipramine (83%). Conclusions: This pilot study suggests a place for cautious initial use of imipramine to reduce ASD symptoms in burned children. Care must be taken to minimize cardiovascular risks in an off-label application of imipramine in children, especially those receiving additional medications.

AB - Objective: Pediatric burn patients often exhibit acute stress disorder (ASD) symptoms. Information on psychopharmacological treatment of ASD symptoms in children is scarce. This pilot study used a prospective, randomized, double-blind design to test whether thermally injured children suffering ASD symptoms benefit from imipramine. Method: Twenty-five children, aged 2 to 19 years, received either imipramine or chloral hydrate for 7 days. A structured interview (clinically useful, but validity and reliability not yet established) was used to assess the presence and frequency of ASD symptoms both before treatment and 3 times during the treatment period. Results: Eleven females and 14 males participated, with a mean total burn surface area of 45% (SD = 23%) and mean age of 8 years (SD = 6). Imipramine was more effective than chloral hydrate in treating ASD symptoms (χ 2 [1, N = 25] = 5.24, p < .02). Five of 13 were positive responders to chloral hydrate (38%). Ten of 12 were positive responders to low-dose imipramine (83%). Conclusions: This pilot study suggests a place for cautious initial use of imipramine to reduce ASD symptoms in burned children. Care must be taken to minimize cardiovascular risks in an off-label application of imipramine in children, especially those receiving additional medications.

KW - Acute stress disorder

KW - Imipramine

KW - Medication therapy

KW - Pharmacotherapy

KW - Posttraumatic stress disorder

UR - http://www.scopus.com/inward/record.url?scp=0033065691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033065691&partnerID=8YFLogxK

U2 - 10.1097/00004583-199907000-00018

DO - 10.1097/00004583-199907000-00018

M3 - Article

C2 - 10405506

AN - SCOPUS:0033065691

VL - 38

SP - 873

EP - 882

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 7

ER -